Skip to main content
Premium Trial:

Request an Annual Quote

BD Fiscal Q1 Revenues Rise 10 Percent, R&D Surges 185 Percent, Profit Slides 35 Percent

NEW YORK (GenomeWeb News) — Becton Dickinson today said fiscal first-quarter 2007 revenues increased 8 percent as R&D spending surged 185 percent and profit dropped 35 percent.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $1.5 billion from $1.4 billion year over year.
 
BD said revenues from its Diagnostics segment increased 2 percent to $442 million, while Biosciences revenue increased 11 percent to $232 million. Revenue from the Medical segment climbed 10 percent to $826 million.    
 
R&D spending for the quarter increased to $195 million from $68.3 million year over year. Contributing to the increase was a $115-million charge related to the completion of its acquisition of TriPath Imaging.
 
Net profits for the quarter slid to $142.9 million from $217.9 million in the year-ago period.
 
The company did not disclose its cash holdings.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.